Company / PP&E per Share
Nuvation Bio Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $4.13
FY2021-FY2025
Trend
-37.6%
vs FY2024
Sector context
#181 of 191
Health Care
What the data says
Among 191 Health Care companies, Nuvation Bio Inc. is in the bottom 5% for pp&e per share. PP&E per Share has declined for 3 consecutive years, from $4.13 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -25.0%.
Declined from $3.28 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -92.6%
- 5-Year CAGR
- -25.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 37.6% year-over-year.
- Ranks #181 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -37.6% |
| FY2024 | $0.00 | -99.9% |
| FY2023 | $3.28 | -20.6% |
| FY2022 | $4.13 | +3.9% |
| FY2021 | $3.97 | +56206.1% |
| FY2020 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026